Relapsed/Refractory Systemic Light Chain Amyloidosis
1 clinical trials · Condition
◉ Watch Relapsed/Refractory Systemic Light Chain Amyloidosis
| Record | Firm | Date |
|---|---|---|
| A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis) (NCT06292780) | Regeneron Pharmaceuticals | 2024-08-07 |
Track Relapsed/Refractory Systemic Light Chain Amyloidosis automatically
Every clearance here is in the API, with alerts when new ones post.